Possible involvement of the interleukin-15 and interleukin-15 receptor system in a heightened state of lamina propria B cell activation and differentiation in patients with inflammatory bowel disease

Journal of Gastroenterology

Volumn 40, Issue 2, 2005, Pages 128-136

  Nishiwaki, Tsuyoshi ^a   Ina, Kenji ^a   Goto, Hidemi ^a   Watanabe, Osamu ^a   Tsuzuki, Tomoyuki ^a   Furuta, Ryuichi ^a   Ando, Takafumi ^a   Hibi, Kenji ^a   Kusugami, Kazuo ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

B cells; Crohn's disease; Interleukin 15; Interleukin 15 receptor; Ulcerative colitis

Indexed keywords

CD40 LIGAND; IMMUNOGLOBULIN G; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; MESALAZINE; MESSENGER RNA; PREDNISOLONE; RECOMBINANT INTERLEUKIN 15; SALAZOSULFAPYRIDINE;

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; ENTERITIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN PRODUCTION; IMMUNOHISTOLOGY; INTESTINE MUCOSA; LAMINA PROPRIA; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; B-LYMPHOCYTES; CELL DIFFERENTIATION; COLITIS, ULCERATIVE; CROHN DISEASE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-15; INTESTINAL MUCOSA; MICROSCOPY, CONFOCAL; MIDDLE AGED; RECEPTORS, INTERLEUKIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 15844373147     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-004-1510-y     Document Type: Article

References (49)

1. Fiocchi C. Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology 1998;115:182-205.
2. Matsuura T, Kusugami K, Morise K, Fiocchi C. Interleukin-2 and interleukin-2 receptor in inflammatory bowel disease. In: Fiocchi C, editor. Cytokines in inflammatory bowel disease. Austin: RG Landes; 1996. p. 41-56.
3. Schreiber S, MacDermott RP, Raedler A, Pinnau R, Bertrovich MJ, Nash GS. Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease. Gastroenterology 1991;101:1020-30.
4. Haruta J, Kusugami K, Kuroiwa A, Ina K, Shinoda M, Morise K, et al. Phenotypic and functional analysis of lamina propria mononuclear cells from colonoscopic biopsy specimens in patients with ulcerative colitis. Am J Gastroenterol 1992;87:448-54.
5. Matsuura T, West GA, Klein JS, Ferraria L, Fiocchi C. Solube interleukin 2 and CD8 and CD4 receptors in inflammatory bowel disease. Gastroenterology 1992;102:2006-14.
6. Brynskov J, Tvede N, Andersen CB, Vilien M. Increased concentrations of interleukin 1β, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease. Gut 1992;33:55-8.
7. Fiocchi C, Hilfiker ML, Youngman KR, Doerder NC, Finke JH. Interleukin-2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease. Gastroenterology 1984;86:734-42.
8. Sakai T, Kusugami K, Nishimura H, Ando T, Yamaguchi T, Ohsuga M, et al. Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease. Gastroenterology 1998;114:1237-43.
9. Fehniger TA, Caligiuri MA. Interleukin 15: Biology and relevance to human disease. Blood 2001;97:14-32.
10. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, et al. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 1994;264:965-8.
11. Yamaguchi T, Suzuki Y, Katakura R, Ebina T, Yokoyama J, Fujimiya Y. Interleukin-15 effectively potentiates the in vitro tumor-specific activity and proliferation of peripheral blood γδ T cells isolated from glioblastoma patients. Cancer Immunol Immunother 1998;47:97-103.
12. Treiber-Held S, Stewart DM, Barraclough HA, Kurman CC, Nelson DL. Release of sIL-2Rα from and activation of native human peripheral blood mononuclear cells by recombinant IL-15. Clin Immunol Immunopathol 1996;80:67-75.
13. Carson WE, Giri JG, Lindermann MJ, Linett ML, Ahdieh M, Paxton R, et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994;180:1395-403.
14. Wilkinson PC, Liew FY. Chemoattraction of human blood T lymphocytes by interleukin-15. J Exp Med 1995;181:1255-9.
15. Allavena P, Giardina G, Bianchi G, Mantovani A. IL-15 is chemotactic for natural killer cells and stimulates their adhesion to vascular endothelium. J Leukoc Biol 1997;61:729-35.
16. Tagaya Y, Bamford RN, DeFilippis AP, Waldmann TA. IL-15: A pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 1996;4:329-36.
17. Armitage RJ, Macduff BM, Eisenman J, Paxton R, Grabstein KH. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol 1995;154:483-90.
18. McInnes IB, Liew FY. Interleukin 15: A proinflammatory role in rheumatoid arthritis synovitis. Immunol Today 1998;19:75-9.
19. Gamero AM, Ussery D, Reintgen DS, Puleo CA, Djeu JY. Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism. Cancer Res 1995;55:4988-94.
20. Akbar AN, Borthwick NJ, Wickremasinghe RG, Panayoitidis P, Pilling D, Bofill M, et al. Interleukin-2 receptor common γ-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur J Immunol 1996;26:294-9.
21. Lorenz HM, Hieronymus T, Grunke M, Manger B, Kalden JR. Differential role for IL-2 and IL-15 in the inhibition of apoptosis in short term activated human lymphocytes. Scand J Immunol 1997;45:660-9.
22. Vella AT, Dow S, Potter TA, Kappler J, Marrack P. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc Natl Acad Sci U S A 1998;95:3810-5.
23. Carson WE, Fehniger TA, Haldar S, Eckhert K, Lindemann MJ, Lai CF, et al. A potential role for interleukin-15 in the regulation of human natural killer cell survival. J Clin Invest 1997;99:937-43.
24. Girard D, Paquet ME, Paquin R, Beaulieu AD. Differential effects of interleukin-15 (IL-15) and IL-2 on human neutrophils: Modulation of phagocytosis, cytoskeleton rearrangement, gene expression, and apoptosis by IL-15. Blood 1996;88:3176-84.
25. Kirman I, Vainer B, Nielsen OH. Interleukin-15 and its role in chronic inflammatory diseases. Inflamm Res 1998;47:285-9.
26. Kirman I, Nielsen OH. Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. Am J Gastroenterol 1996;91:1789-94.
27. Liu Z, Geboes K, Colpaert S, D'Haens GR, Rutgeerts P, Ceuppens JL. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production. J Immunol 2000;164:3608-15.
28. Brandtzaeg P, Baklien K, Fausa O, Hoel PS. Immunohistochemical characterization of local immunoglobulin formation in ulcerative colitis. Gastroenterology 1974;66:1123-36.
29. Baklien K, Brandtzaeg P. Immunohistochemical characterization of local immunoglobulin formation in Crohn's disease of the ileum. Scand J Gastroenterol 1976;11:447-57.
30. Meijer CJ, Bosman FT, Lindeman J. Evidence for predominant involvement of the B-cell system in the inflammatory process in Crohn's disease. Scand J Gastroenterol 1979;14:21-32.
31. Scott MG, Nahm MH, Macke K, Nash GS, Bertovich MJ, MacDermott RP. Spontaneous secretion of IgG subclasses by intestinal mononuclear cells: differences between ulcerative colitis, Crohn's disease, and controls. Clin Exp Immunol 1986;66:209-15.
32. Brandtzaeg P, Haraldsen G, Rugtveit J. Immunopathology of human inflammatory bowel disease. Springer Semin Immunopathol 1997;18:555-89.
33. Ando T, Kusugami K, Ohsuga M, Shinoda M, Sakakibara M, Saito H, et al. Interleukin-8 activity correlates with histological severity in Helicobacter pylori-associated antral gastritis. Am J Gastroenterol 1996;91:1150-6.
34. Kusugami K, Ando T, Ohsuga M, Imada A, Shinoda M, Konagaya T, et al. Mucosal chemokine activity in Helicobacter pylori infection. J Clin Gastroenterol 1997;25:S203-10.
35. Kusugami K, Ando T, Imada A, Ina K, Ohsuga M, Shimizu T, et al. Mucosal macrophage inflammatory protein-1α activity in Helicobacter pylori infection. J Gastroenterol Hepatol 1999;14: 20-6.
36. Suzuki T, Ina K, Nishiwaki T, Tsuzuki T, Okada T, Furuta R, et al. Differential roles of interleukin-1β and interleukin-8 in neutrophil transendothelial migration in patients with Helicobacter pylori infection. Scand J Gastroenterol 2004;39:313-21.
37. Zambello R, Facco M, Trentin L, Sancetta R, Tassinari C, Perin A, et al. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood 1997;89:201-11.
38. Kyokane K, Ito M, Sato Y, Ina K, Ando T, Kusugami K. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia. J Pathol 1998;184:382-9.
39. Imada A, Ina K, Shimada M, Yokoyama T, Yokoyama Y, Nishio Y, et al. Coordinate upregulation of interleukin-8 and growth-related gene product-α is present in the colonic mucosa of inflammatory bowel disease. Scand J Gastroenterol 2001;36:854-64.
40. Shimada M, Ina K, Kyokane K, Imada A, Yamaguchi H, Nihio Y, et al. Upregulation of mucosal soluble Fas ligand and interferon-γ may be involved in ulcerogenesis in patients with Helicobacter pylori-positive gastric ulcer. Scand J Gastroenterol 2002;37:501-11.
41. Kuno Y, Ina K, Nishiwaki T, Tsuzuki T, Shimada M, Imada A, et al. Possible involvement of neutrophil elastase in impaired mucosal repair in patients with ulcerative colitis. J Gastroenterol 2002;37(Suppl 14):22-32.
42. Kusugami K, Fukatsu A, Tanimoto M, Shinoda M, Haruta J, Kuroiwa A, et al. Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependent. Dig Dis Sci 1995;40:949-59.
43. Sakai T, Kimura Y, Inagaki-Ohara K, Kusugami K, Lynch DH, Yoshikai Y. Fas-mediated cytotoxicity by intestinal intraepithelial lymphocytes during acute graft-versus-host disease in mice. Gastroenterology 1997;113:168-74.
44. Chae DW, Nosaka Y, Strom TB, Maslinski W. Distribution of IL-15 receptor α-chains on human peripheral blood mononuclear cells and effect of immunosuppresive drugs on receptor expression. J Immunol 1996;157:2813-9.
45. Kusugami K, Ina K, Ando T, Sakai T, Noshiro M, Shimada M, et al. Modulatory effects of interleukin-15 on mucosal mononuclear cells: implications in the pathogenesis of inflammatory bowel disease. In: Shimoyama T, Lee A, Axon A, Podolsky DK, O'Morain C, editors. Helicobacter meets inflammatory bowel disease. Tokyo: Axel Springer Japan; 1999. p. 45-61.
46. Noelle RJ, Roy M, Shepherd DM, Stamenkovic I, Ledbetter JA, Aruffo A. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci U S A 1992;89:6550-4.
47. Spriggs MK, Armitage RJ, Strockbine L, Clifford KN, Macduff BM, Sato TA, et al. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med 1992;176:1543-50.
48. Splawski JB, Fu SM, Lipsky PE. Immunoregulatory role of CD40 in human B cell differentiation. J Immunol 1993;150:1276-85.
49. Hiroi T, Yanagita M, Ohta N, Sakaue G, Kiyono H. IL-15 and IL-15 receptor selectively regulate differentiation of common mucosal immune system-independent B-1 cells for IgA responses. J Immunol 2000;165:4329-37.